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Background: Prevalence of The transmitted HIV drug resistance (THDR) has been reported in many countries. In
China, the low level THDR was found in only a few provinces. To know the transmitted HIV drug resistance in east
of China, we investigated THDR during 2009–2011 in Jiangsu province of China.
Methods: Between January and August of 2009, 2010, and 2011, we consecutively collected 50, 54, 53 blood
specimens respectively from qualified individuals at surveillance sentinel sites in Jiangsu province according to
protocol of HIV Drug Resistance Threshold Survey (HIVDR-TS) recommended by WHO. The region of pol gene
including protease and partial retro-transcriptase was amplified, sequenced and edited. Then the sequences were
submitted to HIV drug resistance database to analysis transmitted HIV drug resistance mutations using Calibrated
Population Resistance tool. The reference sequences of different HIV-1 subtypes were downloaded from HIV
database and Genebank. The phylogenetic trees were inferred using the neighbor-joining method.
Results: Our results show that THDR has been at low level from 2009 to 2011, only K101E and V179D mutation
was detected which did not belong to the major HIV-1 drug resistance mutations. Phylogenetic analysis showed that
CRF01_AE is the predominant subtype, and followed by CRF07_BC and B subtype. Subtype B consists of the two
distinct clusters.
Conclusions: The low level of THDR suggests that anti-retroviral treatment was implemented more effectively and
THDR surveillance should be conducted two years later in Jiangsu province of China. CRF01_AE has become the
predominant subtype and dual infection of HIV may be common in Jiangsu province.
Keywords: HIV-1, The transmitted HIV drug resistance mutation, SubtypeBackground
By the end of 2011, it was estimated that more than
780,000 people lived with HIV-1 and a cumulative total
of 157,050 AIDS patients had received antiretroviral
therapy in China [1]. In order to curb rapid HIV trans-
mission and improve the quality of life for people living
with HIV, the national level antivirus treatment program
began in 2002 [2]. During the first two years of the pro-
gram, the prevalence of HIV drug resistance among
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unless otherwise stated.months reached to 62.7% [3]. Furthermore, some studies
showed that the HIV-1 drug resistance among naive
AIDS patients ranged from 2.8% to20.2% in China [4-8].
Currently, the most popular HAART regimens consist
of six drugs which are lamivudine (3TC), Stavudine
(D4T), Efavirenz (EFV), Nevirapine (NVP), Zidovudine
(AZT) and Tenofovir (TDF) [9]. Some normal 2nd line
drugs such as tenofovir(TDF) and lopinavir/ritonavir
(LPV/r), were introduced in 2008 but had not been used
widely. The transmission of HIV drug resistance strains
is common in the majority of countries with widely used
ART, especially in developing countries with limited re-
sources [10-13]. Recently, transmitted HIV drug resistanceis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Guo et al. BMC Public Health  (2015) 15:120 Page 2 of 5has been found in a few provinces where ART was intro-
duced earlier in China [9,14-16].
Jiangsu province, located in the east of China, is an
economically developed region with a population of 80
million. The first AIDS case was recorded in 1991 in
Jiangsu, and a total of 5471 cases were reported by the
end of 2011. The Free ART project was initiated in
Jiangsu province in 2005. Up to now, more than 4000
AIDS patients have received free ART. After seven years
of the promotion of free ARF in Jiangsu province, the
prevalence of drug resistance strain among AIDS pa-
tients receiving ART reached to 8.5% [17]. However, it is
unclear whether the transmitted HIV drug resistance
has begun to spread in Jiangsu Province.
To further investigate the prevalence of the transmit-
ted of HIVDR, we conducted the threshold survey of the
transmitted HIV drug resistance among naïve patients
according to the protocol which was recommend by
World Health Organization (WHO)from 2009 to 2011
[18]. In this study, we report the estimated prevalence of
HIVDR transmission and subtypes of transmitted HIVDR
in Jiangsu province of China.
Methods
Between January and August of 2009, 2010, and 2011,
we consecutively collected 50, 54, 53 blood specimens,
respectively from qualified individuals at surveillance
sentinel sites in Jiangsu province according to HIV Drug
Resistance Threshold Survey(HIVDR-TS)by the WHO
for the surveillance of HIVDR in countries with limited
resources. This study was approved by Ethics Committee
of Jiangsu Provincial Center for Disease Prevention and
Control. The written informed consent from participants
was obtained after they knew the objective and content
of this study. No participants less than 18 years old were
involved in this study.
The eligible individuals were recruited according to
HIV Drug Resistance Threshold Survey(HIVDR-TS)by
the WHO for the surveillance of HIVDR in countries
with limited resources [18-20]. According to the WHO
HIVDR-TS protocol, 47 to 50 qualified sequences ob-
tained from consecutively collected HIV-positive speci-
mens are required to determine the level of the
transmitted HIVDR. All eligible individuals were under
age 25 years at HIV diagnosis and no pregnancy history
for females.
A total of 5 mL of whole blood was collected into
EDTA-K3 vacuum tubes. Plasma samples were obtained
by centrifugation and aliquots were stored at −70°C.
Viral RNA was extracted from 140 μL plasma using the
QIAamp Viral RNA Mini kit (Qiagen, Gmbh, Hilden,
Germany) according to the manufacturer’s instruction.
The 1300 bp pol region of HIV-1 includes reverse tran-
scription polymerase and protease gene was amplifiedwith the previous described methods [21]. The viral RNA
was amplified in an one step reverse transcription chain
reaction using SuperScript®IIIone-step RT-PCR with
platinum®Taq kit (Invitrogen, Carlsbad, CA, USA), fol-
lowed by a second round PCR using Platinum®TaqPCRx
DNA Ploymerase kit (Invitrogen, Carlsbad, CA, USA). The
obtained fragments were purified with gel extraction
kit (Qiagen, Gmbh, Hilden, German), and then sequenced
in 3730X DNA Analyzer System.
To eliminate potential laboratory contamination, all
sequences were first subjected to an HIV-1 Blast search
to compare with related reference sequences in the
HIV Databases sponsored of the Division of AIDS of
the National Institute of Allergy and Infectious of
AIDS (NIAID), The National Institute of Health (NIH)
(http://www.ncbi.nlm.nih.gov/). Nucleotide sequences were
aligned with the references using Clustal W algorithm of
MAGE 5.0. Alignment quality, then were checked manu-
ally in Bioedit. The protease and retro-transcriptase muta-
tion were interpreted using the Calibrated Population
Resistance (CPR) tool according to the WHO list for deter-
mination of transmitted HIV-1 DR (http://cpr.standard.
edu/cpr.cgi).
HIV-1 subtypes reference sequences were downloaded
from HIV database (http://www.hiv.lanl.gov/content/
sequence/HIV/mainpage.html). HIV sequences reported
in China were downloaded from Genebank (http://www.
ncbi.nlm.nih.gov/). The phylogenetic trees were inferred
using the neighbor-joining method. All positions contain-
ing gaps and missing data were eliminated from the data-
set. Phylogenetic analyses were conducted in MEGA 5.0.
The GenBank accession numbers of the HIV-1 se-
quences reported in this article are KJ724119 - KJ724248.
Results
The social-demographic data of newly diagnosed HIV-1
positive people
Background information on this newly diagnosed HIV-1
positive population is summarized in Table 1. Among
them, 128 out of 146 (87.7%) were male, and 124
(84.9%) were single; 140 (95.9%) belongs to the Han
ethnic group. As to educational level of them, 44 (30.1%)
received the education of middle school level, 39 (26.7%)
finished high school, and 56 (28.4%) have studied at least
college. There were 31 subjects aged 24 years old (21.2%)
and 28 (19.2%) aged 25 years old. MSM activity (56.8%)
was the main infection route, followed by heterosexual
route (39.1%).
The mutation related to drug resistance
In this study, we were able to consecutively genotype 47
of 50 serum specimens (94%) in 2009, 50 of 54 (92.6%)
in 2010, 49 of 53 (92.5%) in 2011. As shown in Table 2,
the prevalence of transmitted HIV drug resistance was
Table 1 The characteristics of HIV-1 positive individuals
and subtypes circulating among newly diagnosed HIV-1
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Table 2 The mutations related to HIV-1 drug resistance
among newly diagnosed HIVcp1 positive population less
than 25 years old
Mutation Year
2009 2010 2011
V179D 1(2.1%) 1(2.0%) 1(2.0%)
K101E 0(0.0%) 1(2.0%) 1(2.0%)
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in 2011, respectively. Only two mutations associated with
DR were found. They are K101E and V179D mutation.K101E mutation can cause intermediate resistance to NVP
and delairdine (DLV) and low-level resistance to EFV
and etravirine (ETR). V179D mutation is a borderline/
suspicious mutation associated with transmitted HIVDR
can reduce the susceptibility of NVP, EFV, and ETR against
HIV. But no major mutation related to NRTI or NNRTI
were found. No mutation related to PI was also found.
Phylogenetic analysis
Based on sequence of the fragment of Protease and par-
tial reverse transcriptase of pol gene, we analyzed the
subtypes of HIV-1 circulating in newly diagnosed HIV-1
positive population. CRF01_AE was predominant, ac-
counting for 56.8%, followed by CRF07_BC (19.9%). B
subtype only reached to 12.3%. CRF08_BC was 7.8% and
only one belonged to C subtype. Unique recombinant
forms (URF) accounted for 8.9% of them. As showed in
Figure 1, two clusters designated cluster 1 and 2 were
observed among B and URFs sequences in phylogenetic
tree analysis, respectively.
Discussion
This is the first study that describes the prevalence of
transmitted HIVDR in the southeast of China. It was
found that the prevalence of transmitted HIVDR was
less than 5%. Moreover, no major HIVDR mutations
were found. The level of transmitted HIVDR was low.
Surveillance may be repeated two years later according
to WHO recommendation [20]. The prevalence of trans-
mitted HIVDR in Jiangsu province is similar to that re-
ported in other regions other than Dehong Prefecture in
Yunnan province where the transmitted HIV reached
medial level [14,21]. However, the major mutation related
HIVDR were found in Henan and Hunan provinces where
ART was launched earlier and HIV and HIVDR prevalence
were higher in these two provinces [21].
In this study, 95.9% were infected with HIV via sexual
transmission routes. MSM has exceeded the heterosex-
ual transmission route. It may indicate in the near fu-
ture, MSM will become the main transmission route in
Jiangsu province. It was partially supported by our un-
published surveillance data that the number of HIV
positive people via MSM was close to those through het-
erosexual behavior among all HIV-1 positive people re-
ported in recent three years.
Figure 1 The phylogenetic tree based on partial pol gene fragment of HIV-1. The tree topologies were inferred by the neighbor-joining
method. Numbers at the nodes represent the percentages of bootstrap values (only values > 75% are shown).
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risk group often synchronized with the changes of HIV
subtypes distribution, followed by the complexity of HIV
virus in this region. In this study, CRF01_AE was
the predominated subtype. However, CRF07_BC/08_BC
(36.8%) had been the major subtypes circulating in
Jiangsu province, followed by CRF01_AE (31.6%) before
2007 [22]. MSM played a very important role in making
this change. Of course, these are other factors contributing
to this change. For example, in previous study, the ages of
subjects ranged from 3 to 56, and transmission routes in-
cluded heterosexual routine, MSM, blood donors, blood
transfusion, intravenous drug users and mother to child
transmission. Nonetheless, as the predominant subtype in
young people, CRF01_AE will remain as the main subtype
circulating in Jiangsu Province in the coming years.As shown in Figure 1, B subtypes circulating in Jiangsu
Province consists of two clusters. In Jiangsu Provinces, B
subtypes has different origin. In early phase of HIV
prevalence in Jiangsu Province, blood donor and blood
transfusion was the major transmission route. Among
blood donors and patients having experienced blood
transfusion, B subtype has been the predominant, these
B subtypes were introduced into Jiangsu Province from
Henan Province which is bordered the north of Jiangsu
Province [22]. The other B subtypes originated from
Thailand B in heterosexual transmission group or from
Europe-America B in men who sex with men.
It is common that MSM often have many sexual partners
and unproductive anal intercourse in China [23]. The
sexual abuse among this population will cause HIV dual
infection and super infection. Therefore, recombination
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Figure 1, URFs sequence reached to 8.9%. It implied that
HIV dual infection was common in this population and it
was supported by the fact that all these URFs sequences
are from MSM. In addition, two URFs clusters suggested
that these URFs had different origins and the recombinant
phenomenon may be common in this population.
Conclusion
It is the first time to report the prevalence of transmitted
HIVDR viruses in Jiangsu province, although the preva-
lence of transmitted HIVDR in the newly diagnosed
HIV-infected population is low. It is critical to continue
the HIVDR surveillance after the promotion of ART
therapy. Our results also indicate that CRF01_AE has
become the predominated subtype and dual infection of
HIV may be common in Jiangsu province. The control
of the sexual transmission of HIV-1 includes MSM and
heterosexual activities would result in decreasing HIV
epidemic in Jiangsu province, China.
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